{
    "symbol": "SSKN",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-09 21:00:04",
    "content": " We are really excited to announce very strong revenues of $9.4 million for the period ending September 30, 2022, representing 22% year-over-year growth driven by record XTRAC sales. We remain excited to capitalize on our catalyst and over the remainder of this year, we will continue to drive XTRAC utilization, grow our presence in our international markets, focused on our direct-to-consumer and direct-to dermatologists to marketing and continue to roll out TheraClearX, which we believe will meaningfully contribute to growing our top-line."
}